Robin Josephs
Known title: DirectorCIK: 0001222801
Robin Josephs's purchase track record
Robin Josephs has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/14/2022 | MFA | $25K | +10.5% | -6.4% | -1.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
No recent news for MFA. The only article listed is about DiviDog and does not mention MFA. Therefore, there are no recent events affecting MFA. The company’s technical and fundamental data remain unchanged. No new developments to report for the past week.
Transaction History
| SAFE | ▼ Sell | Open Market | 9,500 | $138K | 9/9/2026 | View on chart |
| SAFE | ▲ Buy | Grant | 335 | $0 | 7/15/2026 | View on chart |
| SAFE | ▲ Buy | Grant | 8,778 | $0 | 5/14/2026 | View on chart |
| SAFE | ▲ Buy | Grant | 359 | $0 | 4/15/2026 | View on chart |
| SAFE | ▲ Buy | Grant | 362 | $0 | 1/15/2026 | View on chart |
| MFA | ▲ Buy | Option Exercise | 3,473 | — | 1/15/2026 | View on chart |
| SAFE | ▲ Buy | Grant | 346 | $0 | 10/15/2025 | View on chart |
| SAFE | ▲ Buy | Grant | 356 | $0 | 7/15/2025 | View on chart |
| SAFE | ▲ Buy | Grant | 8,761 | $0 | 5/15/2025 | View on chart |
| SAFE | ▲ Buy | Grant | 348 | $0 | 4/15/2025 | View on chart |
| MFA | ▲ Buy | Option Exercise | 3,153 | — | 1/17/2025 | View on chart |
| SAFE | ▲ Buy | Grant | 309 | $0 | 1/15/2025 | View on chart |
| SAFE | ▲ Buy | Grant | 210 | $0 | 10/15/2024 | View on chart |
| SAFE | ▲ Buy | Grant | 238 | $0 | 7/15/2024 | View on chart |
| SAFE | ▲ Buy | Grant | 7,090 | $0 | 5/15/2024 | View on chart |
| SAFE | ▲ Buy | Grant | 274 | $0 | 4/15/2024 | View on chart |
| SAFE | ▼ Sell | Open Market | 1,150 | $25K | 12/12/2023 | View on chart |
| SAFE | ▲ Buy | Grant | 5,342 | $0 | 6/20/2023 | View on chart |
| SAFE | ▼ Sell | Other | 17,799 | $0 | 3/31/2023 | View on chart |
| SAFE | ▼ Sell | Other | 1,780 | $0 | 3/31/2023 | View on chart |
| SAFE | ▼ Sell | Other | 27,242 | $0 | 3/31/2023 | View on chart |
| SAFE | ▼ Sell | Other | 2,102 | $0 | 3/31/2023 | View on chart |
| MFA | ▲ Buy | Open Market | 2,350 | $25K | 9/14/2022 | View on chart |
| SAFE | ▲ Buy | Grant | 11,129 | $0 | 5/12/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Citizens Downgrades Safehold; RBC Lowers Price Target
Citizens Securities downgraded Safehold to Market Perform, while RBC Capital lowered its price target to $13. These moves reflect a more cautious outlook from analysts. The stock is currently trading near its 52-week low, with an RSI of 27.1 indicating oversold conditions.
Citizens Downgrades Safehold; RBC Lowers Price Target. Citizens Securities downgraded Safehold to Market Perform, while RBC Capital lowered its price target to $13. These moves reflect a more cautious outlook from analysts. The stock is currently trading near its 52-week low, with an RSI of 27.1 indicating oversold conditions.